Number of Shares
6.53 Mil
Current Holdings Value*
$25.19 Mil
% of Portfolio
6.47%
Total Estimate Gain
$-83.28 Mil
% of Total Estimate Gain
-76.22%

SR ONE CAPITAL MANAGEMENT, LP's Design Therapeutics Inc Holding Summary

As of 2025-03-31, SR ONE CAPITAL MANAGEMENT, LP held 6.53 Mil shares of Design Therapeutics Inc(DSGN), totaling $25.19 Mil. This investment constitutes 6.47% of their stock portfolio, and SR ONE CAPITAL MANAGEMENT, LP now holds 11.5% of the outstanding Design Therapeutics Inc(DSGN) stock.

The initial trade took place in 2021Q4. And since then SR ONE CAPITAL MANAGEMENT, LP has made 1 purchases of DSGN, at an average price of $16.74, for a total of 6.53 Mil shares. Based on historical transaction data and DSGN's current price of $3.98, SR ONE CAPITAL MANAGEMENT, LP's estimated gain on his DSGN holdings is $-83.28 Mil, reflecting a -76.22% gain to date.

SR ONE CAPITAL MANAGEMENT, LP DSGN ($3.98) Holding Chart

SR ONE CAPITAL MANAGEMENT, LP DSGN ($3.98) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1